A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by HealthCare Pharmaceuticals, Inc.
Sponsor:
Information provided by (Responsible Party):
HealthCare Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01711671
First received: October 18, 2012
Last updated: June 26, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)